Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.
Metformin has been used for alleviating metabolic abnormalities in patients with schizophrenia. The lowest dose of metformin to treat metabolic abnormalities in clozapine-treated patients is 1000 mg/d. This study was designed to determine whether metformin at 500 mg/d and 1000 mg/d is effective in i...
Main Authors: | Chih-Chiang Chiu, Mong-Liang Lu, Ming-Chyi Huang, Po-Yu Chen, Yen-Kuang Lin, Shih-Ku Lin, Chun-Hsin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5156367?pdf=render |
Similar Items
-
Correction: Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study.
by: Chih-Chiang Chiu, et al.
Published: (2018-01-01) -
Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
by: Paria Hebrani, et al.
Published: (2015-01-01) -
Interaction of clozapine with metformin in a schizophrenia rat model
by: G. Horvath, et al.
Published: (2021-08-01) -
Comparison effects of clozapine, ECT and combination ECTand clozapine on resistance treatment of schizophrenia(Double blind)
by: S.H. Hosseini, et al.
Published: (2006-01-01) -
Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial
by: Amir Krivoy, et al.
Published: (2017-12-01)